These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37799011)

  • 21. Validation of factor VIII activity for monitoring standard and extended half-life products and correlation to thrombin generation assays.
    Augustsson C; Norström E; Lind V; Martin M; Astermark J; Strandberg K
    Haemophilia; 2021 May; 27(3):494-500. PubMed ID: 33866649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of the new ReFacto AF Laboratory Standard allows reliable measurement of FVIII:C levels in ReFacto AF mock plasma samples by a one-stage clotting assay.
    Pouplard C; Caron C; Aillaud MF; Ternisien C; Desconclois C; Dubanchet A; Sobas F
    Haemophilia; 2011 Sep; 17(5):e958-62. PubMed ID: 21457408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measuring FVIII activity of glycopegylated recombinant factor VIII, N8-GP, with commercially available one-stage clotting and chromogenic assay kits: a two-centre study.
    Hillarp A; Bowyer A; Ezban M; Persson P; Kitchen S
    Haemophilia; 2017 May; 23(3):458-465. PubMed ID: 28198071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94-9027) for haemophilia A.
    Gu JM; Ramsey P; Evans V; Tang L; Apeler H; Leong L; Murphy JE; Laux V; Myles T
    Haemophilia; 2014 Jul; 20(4):593-600. PubMed ID: 24471985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of an automated chromogenic assay for Factor VIII clotting activity measurement in patients affected by haemophilia A.
    Novembrino C; Boscolo Anzoletti M; Mancuso ME; Shinohara S; Peyvandi F
    Haemophilia; 2019 May; 25(3):521-526. PubMed ID: 31044485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of three automated chromogenic FVIII kits for the diagnosis of mild discrepant haemophilia A.
    Rodgers SE; Duncan EM; Sobieraj-Teague M; Lloyd JV
    Int J Lab Hematol; 2009 Apr; 31(2):180-8. PubMed ID: 18190586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance evaluation of Revohem
    Suzuki A; Suzuki N; Kanematsu T; Shinohara S; Arai N; Kikuchi R; Matsushita T
    Int J Lab Hematol; 2019 Oct; 41(5):664-670. PubMed ID: 31271527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimation of Nuwiq
    Tiefenbacher S; Albisetti M; Baker P; Kappert G; Kitchen S; Kremer Hovinga JA; Pouplard C; Scholz U; Ternisien C; Borgvall C; Vicente T; Belyanskaya L; Walter O; Oldenburg J;
    Haemophilia; 2019 Jul; 25(4):708-717. PubMed ID: 31106957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susoctocog-alfa (Obizur
    Zanon E; Pasca S; Borchiellini A; Lodigiani C; Molinari AC; Ambaglio C; Valeri F; Preti PS; Moscatelli P; Simioni P
    Blood Transfus; 2020 Jul; 18(4):312-321. PubMed ID: 32698943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor VIII and IX assays for post-infusion monitoring in hemophilia patients: Guidelines from the French BIMHO group (GFHT).
    Jeanpierre E; Pouplard C; Lasne D; Le Cam Duchez V; Eschwege V; Flaujac C; Galinat H; Harzallah I; Proulle V; Smahi M; Sobas F; Stepina N; Toulon P; Voisin S; Ternisien C; Nougier C;
    Eur J Haematol; 2020 Aug; 105(2):103-115. PubMed ID: 32277501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factor VIII chromogenic assays can be used for potency labeling and postadministration monitoring of N8-GP.
    Pickering W; Hansen M; Kjalke M; Ezban M
    J Thromb Haemost; 2016 Aug; 14(8):1579-87. PubMed ID: 27241682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of a next generation factor VIII mimetic bispecific antibody (Mim8) on assays of factor VIII activity and thrombin generation.
    Bowyer AE; Kitchen S; Ezban M
    J Thromb Haemost; 2023 Mar; 21(3):480-487. PubMed ID: 36696203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter performance evaluation and reference range determination of a new one-stage factor VIII assay.
    Lowe AE; Jones R; Kitchen S; Geisen U; Rozsnyai G; Jilma P; Quehenberger P
    J Clin Lab Anal; 2022 Apr; 36(4):e24294. PubMed ID: 35274775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of N8-GP Activity Using a One-Stage Clotting Assay: A Single-Center Experience.
    Hegemann I; Koch K; Clausen WHO; Ezban M; Brand-Staufer B
    Acta Haematol; 2020; 143(5):504-508. PubMed ID: 31639805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of recombinant anti-haemophilic porcine sequence factor VIII in adults with acquired haemophilia A.
    Fosbury E; Drebes A; Riddell A; Chowdary P
    Ther Adv Hematol; 2017 Sep; 8(9):263-272. PubMed ID: 29051804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cost-effective approach to factor assay calibration using a truncated live calibration curve.
    Guy S; Sermon-Cadd AM; Shepherd FM; Kitchen S; Bowyer AE
    Int J Lab Hematol; 2019 Oct; 41(5):679-683. PubMed ID: 31421012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discrepancy between the results of one-stage and chromogenic factor VIII: C assays in patients with mild/moderate hemophilia A.
    Vosough F; Ahmadinejad M; Toogeh G; Karimi K; Homayoun S; Managhchi MR; Arabkhazaeli A
    Blood Coagul Fibrinolysis; 2020 Dec; 31(8):530-535. PubMed ID: 33141777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromogenic assay for BAY 81-8973 potency assignment has no impact on clinical outcome or monitoring in patient samples.
    Kitchen S; Katterle Y; Beckmann H; Maas Enriquez M
    J Thromb Haemost; 2016 Jun; 14(6):1192-9. PubMed ID: 27002680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Emicizumab on APTT, FVIII assays and FVIII Inhibitor assays using different reagents: Results of a UK NEQAS proficiency testing exercise.
    Lowe A; Kitchen S; Jennings I; Kitchen DP; Woods TAL; Walker ID
    Haemophilia; 2020 Nov; 26(6):1087-1091. PubMed ID: 33094895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of one-stage and chromogenic factor VIII assays to tailor the dose of recombinant factor VIII-Fc fusion protein (rFVIIIFc, efmoroctocog alfa) in adult patients with haemophilia A: Single-centre, real-world experience of surgery.
    Désage S; Nougier C; Meunier S; Chamouard V; Jousselme E; Dargaud Y; Lienhart A
    Haemophilia; 2024 Mar; 30(2):538-544. PubMed ID: 38149726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.